14-93721486-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_178013.4(PRIMA1):c.420G>A(p.Ser140=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.628 in 1,612,388 control chromosomes in the GnomAD database, including 323,011 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.58 ( 26673 hom., cov: 31)
Exomes 𝑓: 0.63 ( 296338 hom. )
Consequence
PRIMA1
NM_178013.4 synonymous
NM_178013.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.83
Genes affected
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.7).
BP6
Variant 14-93721486-C-T is Benign according to our data. Variant chr14-93721486-C-T is described in ClinVar as [Benign]. Clinvar id is 586377.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.83 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.66 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PRIMA1 | NM_178013.4 | c.420G>A | p.Ser140= | synonymous_variant | 5/5 | ENST00000393140.6 | NP_821092.1 | |
PRIMA1 | XM_011536456.3 | c.420G>A | p.Ser140= | synonymous_variant | 5/5 | XP_011534758.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PRIMA1 | ENST00000393140.6 | c.420G>A | p.Ser140= | synonymous_variant | 5/5 | 1 | NM_178013.4 | ENSP00000376848 | P1 | |
PRIMA1 | ENST00000393143.5 | c.420G>A | p.Ser140= | synonymous_variant | 4/4 | 1 | ENSP00000376851 | P1 | ||
PRIMA1 | ENST00000316227.3 | c.*216G>A | 3_prime_UTR_variant | 5/5 | 1 | ENSP00000320948 | ||||
PRIMA1 | ENST00000477603.5 | c.*216G>A | 3_prime_UTR_variant, NMD_transcript_variant | 6/6 | 1 | ENSP00000434370 |
Frequencies
GnomAD3 genomes AF: 0.582 AC: 88386AN: 151830Hom.: 26667 Cov.: 31
GnomAD3 genomes
AF:
AC:
88386
AN:
151830
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.607 AC: 152360AN: 251012Hom.: 47664 AF XY: 0.610 AC XY: 82765AN XY: 135652
GnomAD3 exomes
AF:
AC:
152360
AN:
251012
Hom.:
AF XY:
AC XY:
82765
AN XY:
135652
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.633 AC: 924802AN: 1460440Hom.: 296338 Cov.: 41 AF XY: 0.632 AC XY: 459312AN XY: 726606
GnomAD4 exome
AF:
AC:
924802
AN:
1460440
Hom.:
Cov.:
41
AF XY:
AC XY:
459312
AN XY:
726606
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.582 AC: 88431AN: 151948Hom.: 26673 Cov.: 31 AF XY: 0.583 AC XY: 43262AN XY: 74250
GnomAD4 genome
AF:
AC:
88431
AN:
151948
Hom.:
Cov.:
31
AF XY:
AC XY:
43262
AN XY:
74250
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1555
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Apr 20, 2017 | - - |
Sleep-related hypermotor epilepsy Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at